This podcast miniseries is supported by an educational grant from Merck & Co., Inc.
In the third of three podcasts focusing on cough, miniseries host Dr. Purvi Parikh joins with Dr. Kevin Murphy and Dr. Mandel Sher to look at what does and doesn’t work in treating cough. They review the current therapies and what new therapies options are coming in the future.
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Today’s speakers have the following disclosures:
- Kevin Murphy, MD: Honoraria: AstraZeneca, Genentech, Novartis, Sanofi, Regeneron
- Purvi Parikh, MD: Honoraria: AstraZeneca, Takeda, Genentech/Novartis, Aimmune; Contracted research: AstraZeneca
- Mandel Sher, MD: Advisory Committee, Consulting Fee: Merck; Speaker, Honorarium: Optinose; Consulting, Fee: NeRRe; Clinical Investigator, Contracted Research: Attenua, Merck, NeRRe
We’re pleased to introduce CME credit for this episode of AllergyTalk! Get credit for this episode.
Cough Miniseries – Episode 3
ACAAI presents this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to the procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that may be referenced.
